insights_auto
Why is GH up 2,54%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
US$182,59
arrow_upward
+2,54%(+4,53) 1D
US$181,07
arrow_downward
-0,83% (-1,52)bedtimeAfter hours
Closed: 28 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$178,06
High
US$186,03
Low
US$177,00
Mkt. cap
24,50 ຕື້
Avg. vol.
1,85 ລ້ານ
Volume
186,00
52-wk high
US$191,01
52-wk low
US$68,02
EPS
US$-3,50
Beta
1,58
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
Open
US$178,06
High
US$186,03
Low
US$177,00
Mkt. cap
24,50 ຕື້
Avg. vol.
1,85 ລ້ານ
Volume
186,00
52-wk high
US$191,01
52-wk low
US$68,02
EPS
US$-3,50
Beta
1,58
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Investing.com
·
1 ມື້ກ່ອນ
BTIG raises Guardant Health stock price target on growth outlook
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth care provider
Websiteguardanthealth.com